BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30348519)

  • 1. Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.
    Cibula D; Abu-Rustum NR; Fischerova D; Pather S; Lavigne K; Slama J; Alektiar K; Ming-Yin L; Kocian R; Germanova A; Frühauf F; Dostalek L; Dusek L; Narayan K
    Gynecol Oncol; 2018 Dec; 151(3):438-443. PubMed ID: 30348519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
    Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
    Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.
    Rushdan MN; Tay EH; Khoo-Tan HS; Lee KM; Low JH; Ho TH; Yam KL
    Ann Acad Med Singap; 2004 Jul; 33(4):467-72. PubMed ID: 15329758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
    Tuipae S; Yanaranop M; Oniem N
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
    Yeo RM; Chia YN; Namuduri RP; Yap SP; Soong YL; Yam PK; Lim TY; Khoo-Tan HS
    Gynecol Oncol; 2011 Nov; 123(2):225-9. PubMed ID: 21782226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
    Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
    Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
    Nasioudis D; Latif NA; Giuntoli Ii RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Ko EM
    Int J Gynecol Cancer; 2021 Jun; 31(6):829-834. PubMed ID: 33962994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
    Tomita N; Mizuno M; Kondo S; Mori M; Takeshita S; Sakata J; Tsubouchi H; Kodaira T
    Int J Gynecol Cancer; 2018 Jul; 28(6):1211-1217. PubMed ID: 29727352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
    van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
    Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.